
Olga V. Tcherkasskaya
Examiner (ID: 5403, Phone: (571)270-3672 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615 |
| Total Applications | 928 |
| Issued Applications | 461 |
| Pending Applications | 124 |
| Abandoned Applications | 380 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19316693
[patent_doc_number] => 20240238233
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => Pharmaceutical Composition and Method for Improving Biomechanical Integrity of the Pelvic Floor
[patent_app_type] => utility
[patent_app_number] => 18/411193
[patent_app_country] => US
[patent_app_date] => 2024-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9039
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18411193
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/411193 | Pharmaceutical Composition and Method for Improving Biomechanical Integrity of the Pelvic Floor | Jan 11, 2024 | Pending |
Array
(
[id] => 19111152
[patent_doc_number] => 20240122902
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS
[patent_app_type] => utility
[patent_app_number] => 18/391451
[patent_app_country] => US
[patent_app_date] => 2023-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14138
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18391451
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/391451 | Treatment of idiopathic pulmonary fibrosis | Dec 19, 2023 | Issued |
Array
(
[id] => 19125643
[patent_doc_number] => 20240130996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-25
[patent_title] => PHARMACEUTICAL COMPOSITIONS AND PHARMACOKINETICS OF A GAMMA-HYDROXYBUTYRIC ACID DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 18/533982
[patent_app_country] => US
[patent_app_date] => 2023-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15265
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18533982
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/533982 | PHARMACEUTICAL COMPOSITIONS AND PHARMACOKINETICS OF A GAMMA-HYDROXYBUTYRIC ACID DERIVATIVE | Dec 7, 2023 | Pending |
Array
(
[id] => 19700039
[patent_doc_number] => 12194037
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-14
[patent_title] => Apparatus, methods, and systems for providing pharmaceutical compositions and administering medications to patients
[patent_app_type] => utility
[patent_app_number] => 18/529978
[patent_app_country] => US
[patent_app_date] => 2023-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 56
[patent_figures_cnt] => 102
[patent_no_of_words] => 39313
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 189
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18529978
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/529978 | Apparatus, methods, and systems for providing pharmaceutical compositions and administering medications to patients | Dec 4, 2023 | Issued |
Array
(
[id] => 19049239
[patent_doc_number] => 20240091208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING VENGLUSTAT
[patent_app_type] => utility
[patent_app_number] => 18/515897
[patent_app_country] => US
[patent_app_date] => 2023-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12805
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18515897
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/515897 | PHARMACEUTICAL COMPOSITIONS COMPRISING VENGLUSTAT | Nov 20, 2023 | Pending |
Array
(
[id] => 19081803
[patent_doc_number] => 20240108604
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS
[patent_app_type] => utility
[patent_app_number] => 18/513181
[patent_app_country] => US
[patent_app_date] => 2023-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14109
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18513181
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/513181 | Treatment of idiopathic pulmonary fibrosis | Nov 16, 2023 | Issued |
Array
(
[id] => 19032444
[patent_doc_number] => 20240082259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => QUETIAPINE ORAL LIQUID SUSPENSION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/507884
[patent_app_country] => US
[patent_app_date] => 2023-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14992
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18507884
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/507884 | QUETIAPINE ORAL LIQUID SUSPENSION AND USE THEREOF | Nov 12, 2023 | Pending |
Array
(
[id] => 19032444
[patent_doc_number] => 20240082259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => QUETIAPINE ORAL LIQUID SUSPENSION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/507884
[patent_app_country] => US
[patent_app_date] => 2023-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14992
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18507884
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/507884 | QUETIAPINE ORAL LIQUID SUSPENSION AND USE THEREOF | Nov 12, 2023 | Pending |
Array
(
[id] => 19170870
[patent_doc_number] => 20240156844
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-16
[patent_title] => ORALLY ADMINISTRABLE FORMULATION
[patent_app_type] => utility
[patent_app_number] => 18/506793
[patent_app_country] => US
[patent_app_date] => 2023-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7866
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18506793
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/506793 | ORALLY ADMINISTRABLE FORMULATION | Nov 9, 2023 | Pending |
Array
(
[id] => 19140333
[patent_doc_number] => 20240139109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => PHARMACEUTICAL FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 18/501714
[patent_app_country] => US
[patent_app_date] => 2023-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24424
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18501714
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/501714 | PHARMACEUTICAL FORMULATIONS | Nov 2, 2023 | Pending |
Array
(
[id] => 19140333
[patent_doc_number] => 20240139109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => PHARMACEUTICAL FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 18/501714
[patent_app_country] => US
[patent_app_date] => 2023-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24424
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18501714
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/501714 | PHARMACEUTICAL FORMULATIONS | Nov 2, 2023 | Pending |
Array
(
[id] => 19018806
[patent_doc_number] => 20240074977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => LYOPHILIZED FORMULATIONS OF TEGAVIVINT
[patent_app_type] => utility
[patent_app_number] => 18/383389
[patent_app_country] => US
[patent_app_date] => 2023-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9202
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18383389
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/383389 | Lyophilized formulations of tegavivint | Oct 23, 2023 | Issued |
Array
(
[id] => 19065800
[patent_doc_number] => 20240100226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-28
[patent_title] => WATER-SOLUBLE SALT PARTICLE CONTAINING COMPOSITIONS AND POROUS MATERIALS MADE THEREFROM
[patent_app_type] => utility
[patent_app_number] => 18/380350
[patent_app_country] => US
[patent_app_date] => 2023-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13090
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18380350
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/380350 | WATER-SOLUBLE SALT PARTICLE CONTAINING COMPOSITIONS AND POROUS MATERIALS MADE THEREFROM | Oct 15, 2023 | Pending |
Array
(
[id] => 19921791
[patent_doc_number] => 12296050
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-13
[patent_title] => Pharmaceutical compositions comprising maralixibat and uses thereof
[patent_app_type] => utility
[patent_app_number] => 18/377216
[patent_app_country] => US
[patent_app_date] => 2023-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 39
[patent_no_of_words] => 37446
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18377216
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/377216 | Pharmaceutical compositions comprising maralixibat and uses thereof | Oct 4, 2023 | Issued |
Array
(
[id] => 18901267
[patent_doc_number] => 20240016752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => POLYMERIZED WHEY PROTEIN ENCAPSULATED ANTIOXIDANT COMPOUND AND A PROCESS FOR PREPARATION OF SAME
[patent_app_type] => utility
[patent_app_number] => 18/474553
[patent_app_country] => US
[patent_app_date] => 2023-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9433
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18474553
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/474553 | Polymerized whey protein encapsulated antioxidant compound and a process for preparation of same | Sep 25, 2023 | Issued |
Array
(
[id] => 19049180
[patent_doc_number] => 20240091149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => COMPOSITIONS AND METHODS FOR IMPROVING GASTROINTESTINAL ABSORPTION OF ELECTROLYTES
[patent_app_type] => utility
[patent_app_number] => 18/469299
[patent_app_country] => US
[patent_app_date] => 2023-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5457
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18469299
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/469299 | COMPOSITIONS AND METHODS FOR IMPROVING GASTROINTESTINAL ABSORPTION OF ELECTROLYTES | Sep 17, 2023 | Pending |
Array
(
[id] => 18829125
[patent_doc_number] => 20230397647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => CHEWABLE DISSOLVABLE NICOTINE TABLET
[patent_app_type] => utility
[patent_app_number] => 18/456763
[patent_app_country] => US
[patent_app_date] => 2023-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9733
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18456763
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/456763 | CHEWABLE DISSOLVABLE NICOTINE TABLET | Aug 27, 2023 | Pending |
Array
(
[id] => 18829125
[patent_doc_number] => 20230397647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => CHEWABLE DISSOLVABLE NICOTINE TABLET
[patent_app_type] => utility
[patent_app_number] => 18/456763
[patent_app_country] => US
[patent_app_date] => 2023-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9733
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18456763
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/456763 | CHEWABLE DISSOLVABLE NICOTINE TABLET | Aug 27, 2023 | Pending |
Array
(
[id] => 18841728
[patent_doc_number] => 20230404131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => DISSOLVABLE-CHEWABLE EXHAUSTED-TOBACCO TABLET
[patent_app_type] => utility
[patent_app_number] => 18/455799
[patent_app_country] => US
[patent_app_date] => 2023-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10421
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18455799
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/455799 | DISSOLVABLE-CHEWABLE EXHAUSTED-TOBACCO TABLET | Aug 24, 2023 | Pending |
Array
(
[id] => 18841728
[patent_doc_number] => 20230404131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => DISSOLVABLE-CHEWABLE EXHAUSTED-TOBACCO TABLET
[patent_app_type] => utility
[patent_app_number] => 18/455799
[patent_app_country] => US
[patent_app_date] => 2023-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10421
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18455799
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/455799 | DISSOLVABLE-CHEWABLE EXHAUSTED-TOBACCO TABLET | Aug 24, 2023 | Pending |